Values CatLog read from this paper
Identification of a hydrophobic exosite on tissue type plasminogen activator that modulates specificity for plasminogen
PMID 8999865doi:10.1074/jbc.272.3.1811Open in Browse
The paper itself is not on this site: read it at the publisher. This page lists only the values CatLog read from it.
CatLog read 60 records (180 values) from this paper: tissue type plasminogen activator (t-PA) from Homo sapiens.
Read from the paper by an AI model and checked against the paper by a second, separate AI run; code converted the units. Values are in CatLog's units; each record opens in Browse with the line the paper prints and the checks.
| Enzyme | Organism | Substrate | kcat (s⁻¹) | Km (mM) | kcat/Km (mM⁻¹ s⁻¹) | Conditions | Open record |
|---|---|---|---|---|---|---|---|
| tissue type plasminogen activator (t-PA) | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.1 | 1.1 × 10⁻⁵ | 9.1 × 10³ | Open record: tissue type plasminogen activator (t-PA), Lys-plasminogen | |
| tissue type plasminogen activator (t-PA) | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.068 | 0.005 | 14 | Open record: tissue type plasminogen activator (t-PA), Lys-plasminogen | |
| tissue type plasminogen activator (t-PA) | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 47 | 0.4 | 120 | Open record: tissue type plasminogen activator (t-PA), methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant F423A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.12 | 1.4 × 10⁻⁵ | 8.6 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant F423A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.02 | 0.004 | 5 | Open record: tissue type plasminogen activator (t-PA) variant F423A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423A | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 49 | 0.5 | 98 | Open record: tissue type plasminogen activator (t-PA) variant F423A, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant F423A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.2 | 2.2 × 10⁻⁵ | 9.1 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant F423A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.004 | 0.01 | 0.4 | Open record: tissue type plasminogen activator (t-PA) variant F423A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423A/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 27 | 1 | 27 | Open record: tissue type plasminogen activator (t-PA) variant F423A/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant F423E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.18 | 2.3 × 10⁻⁵ | 7.8 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant F423E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.017 | 0.005 | 3.4 | Open record: tissue type plasminogen activator (t-PA) variant F423E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 57 | 0.5 | 110 | Open record: tissue type plasminogen activator (t-PA) variant F423E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant F423E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 1.5 × 10⁻⁵ | 1 × 10⁴ | Open record: tissue type plasminogen activator (t-PA) variant F423E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.003 | 0.008 | 0.38 | Open record: tissue type plasminogen activator (t-PA) variant F423E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423E/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 28 | 0.9 | 31 | Open record: tissue type plasminogen activator (t-PA) variant F423E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant L420A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.17 | 1.9 × 10⁻⁵ | 8.9 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant L420A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.014 | 0.001 | 14 | Open record: tissue type plasminogen activator (t-PA) variant L420A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420A | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 45 | 0.4 | 110 | Open record: tissue type plasminogen activator (t-PA) variant L420A, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant L420A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.18 | 1.4 × 10⁻⁵ | 1.3 × 10⁴ | Open record: tissue type plasminogen activator (t-PA) variant L420A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.008 | 0.009 | 0.89 | Open record: tissue type plasminogen activator (t-PA) variant L420A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420A/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 42 | 1.3 | 32 | Open record: tissue type plasminogen activator (t-PA) variant L420A/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant L420E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.17 | 2.1 × 10⁻⁵ | 8.1 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant L420E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.005 | 7 × 10⁻⁴ | 7.1 | Open record: tissue type plasminogen activator (t-PA) variant L420E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 45 | 0.4 | 110 | Open record: tissue type plasminogen activator (t-PA) variant L420E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant L420E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 1.8 × 10⁻⁵ | 8.3 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant L420E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.002 | 0.005 | 0.4 | Open record: tissue type plasminogen activator (t-PA) variant L420E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420E/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 29 | 0.9 | 32 | Open record: tissue type plasminogen activator (t-PA) variant L420E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.11 | 1.3 × 10⁻⁵ | 8.5 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant P422A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.028 | 0.004 | 7 | Open record: tissue type plasminogen activator (t-PA) variant P422A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422A | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 47 | 0.4 | 120 | Open record: tissue type plasminogen activator (t-PA) variant P422A, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 1 × 10⁻⁵ | 1.5 × 10⁴ | Open record: tissue type plasminogen activator (t-PA) variant P422A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.007 | 0.013 | 0.54 | Open record: tissue type plasminogen activator (t-PA) variant P422A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422A/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 32 | 1.2 | 27 | Open record: tissue type plasminogen activator (t-PA) variant P422A/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 2.9 × 10⁻⁵ | 5.2 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant P422E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.0015 | 7 × 10⁻⁴ | 2.1 | Open record: tissue type plasminogen activator (t-PA) variant P422E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 49 | 0.4 | 120 | Open record: tissue type plasminogen activator (t-PA) variant P422E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.17 | 2.8 × 10⁻⁵ | 6.1 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant P422E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 5 × 10⁻⁴ | 0.005 | 0.1 | Open record: tissue type plasminogen activator (t-PA) variant P422E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422E/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 31 | 1.1 | 28 | Open record: tissue type plasminogen activator (t-PA) variant P422E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422G | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 2.6 × 10⁻⁵ | 5.8 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant P422G, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422G | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.0028 | 6 × 10⁻⁴ | 4.7 | Open record: tissue type plasminogen activator (t-PA) variant P422G, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422G | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 60 | 0.6 | 100 | Open record: tissue type plasminogen activator (t-PA) variant P422G, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422G/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.21 | 2.7 × 10⁻⁵ | 7.8 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant P422G/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422G/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 8 × 10⁻⁴ | 0.004 | 0.2 | Open record: tissue type plasminogen activator (t-PA) variant P422G/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422G/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 14 | 1.7 | 8.2 | Open record: tissue type plasminogen activator (t-PA) variant P422G/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.13 | 1 × 10⁻⁵ | 1.3 × 10⁴ | Open record: tissue type plasminogen activator (t-PA) variant R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.024 | 0.017 | 1.4 | Open record: tissue type plasminogen activator (t-PA) variant R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 33 | 1 | 33 | Open record: tissue type plasminogen activator (t-PA) variant R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant S421E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 1.8 × 10⁻⁵ | 8.3 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant S421E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.016 | 0.003 | 5.3 | Open record: tissue type plasminogen activator (t-PA) variant S421E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 46 | 0.4 | 120 | Open record: tissue type plasminogen activator (t-PA) variant S421E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant S421E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.21 | 2.3 × 10⁻⁵ | 9.1 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant S421E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.002 | 0.007 | 0.29 | Open record: tissue type plasminogen activator (t-PA) variant S421E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421E/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 26 | 2.3 | 11 | Open record: tissue type plasminogen activator (t-PA) variant S421E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant S421G | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.11 | 1.6 × 10⁻⁵ | 6.9 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant S421G, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421G | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.018 | 0.004 | 4.5 | Open record: tissue type plasminogen activator (t-PA) variant S421G, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421G | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 36 | 0.4 | 90 | Open record: tissue type plasminogen activator (t-PA) variant S421G, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant S421G/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.19 | 2.6 × 10⁻⁵ | 7.3 × 10³ | Open record: tissue type plasminogen activator (t-PA) variant S421G/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421G/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.001 | 0.004 | 0.25 | Open record: tissue type plasminogen activator (t-PA) variant S421G/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421G/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 23 | 4.6 | 5 | Open record: tissue type plasminogen activator (t-PA) variant S421G/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline |